Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders. (2021)
Attributed to:
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome(IBS-D)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41588-021-00950-8
PubMed Identifier: 34741163
Publication URI: http://europepmc.org/abstract/MED/34741163
Type: Journal Article/Review
Volume: 53
Parent Publication: Nature genetics
Issue: 11
ISSN: 1061-4036